Retroperitoneal neoplasm and Thrombocytopenia

Summary:

Thrombocytopenia is reported only by a few people with Retroperitoneal neoplasm.

The study analyzes which people have Thrombocytopenia with Retroperitoneal neoplasm. It is created by eHealthMe based on 2 people who have Thrombocytopenia and Retroperitoneal neoplasm from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

2 people who have Retroperitoneal Neoplasm and Thrombocytopenia are studied.

What is Retroperitoneal neoplasm?

Retroperitoneal neoplasm (tumour between peritoneum and the posterior abdominal wall) is found to be associated with 185 drugs and 42 conditions by eHealthMe.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 4,071 drugs and 4,603 conditions by eHealthMe.

Number of Thrombocytopenia in Retroperitoneal neoplasm reports submitted per year:

Would you have Thrombocytopenia when you have Retroperitoneal neoplasm?

Gender of people who have Retroperitoneal Neoplasm and experienced Thrombocytopenia *:

female: 0.0 %
male: 100 %

Age of people who have Retroperitoneal Neoplasm and experienced Thrombocytopenia *:

Common drugs taken by these people *:

Sunitinib Malate: 1 person, 50.00%

Common symptoms for these people *:

Weakness: 1 person, 50.00%
Microangiopathic Haemolytic Anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells): 1 person, 50.00%
Anaemia (lack of blood): 1 person, 50.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Thrombocytopenia?

Check whether Thrombocytopenia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

Related studies

Treatments, associated drugs and conditions:

Retroperitoneal neoplasm (145 reports)
Thrombocytopenia (247,414 reports)

COVID vaccines that are related to Thrombocytopenia:

Common drugs associated with Thrombocytopenia:

All the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (4,071 drugs)

Common conditions associated with Thrombocytopenia:

All the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,603 conditions)

How the study uses the data?

The study is based on Thrombocytopenia and Retroperitoneal neoplasm, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.